Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use

Article, Review English OPEN
Coulston, Carissa M.; Perdices, Michael; Henderson, Antony F.; Malhi, Gin S.;
  • Publisher: Hindawi Publishing Corporation
  • Journal: Schizophrenia Research and Treatment,volume 2,011 (issn: 2090-2085, eissn: 2090-2093)
  • Related identifiers: doi: 10.1155/2011/501726, pmc: PMC3428612
  • Subject: Review Article | Psychiatry | Article Subject | RC435-571

Recent studies have found that cannabinoids may improve neuropsychological performance, ameliorate negative symptoms, and have antipsychotic properties for a subgroup of the schizophrenia population. These findings are in contrast to the longstanding history of adverse ... View more
  • References (106)
    106 references, page 1 of 11

    Andréasson, S., Allebeck, P., Engström, A., Rydberg, U.. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987; 2 (8574): 1483-1486

    Fergusson, D. M., Horwood, L. J., Swain-Campbell, N. R.. Cannabis dependence and psychotic symptoms in young people. Psychological Medicine. 2003; 33 (1): 15-21

    Silva, P. A., Stanton, W. R.. From Child to Adult: The Dunedin Multidisciplinary Health and Development Study. 1996

    Van Os, J., Bak, M., Hanssen, M., Bijl, R. V., De Graaf, R., Verdoux, H.. Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology. 2002; 156 (4): 319-327

    Zammit, S., Allebeck, P., Andréasson, S., Lundberg, I., Lewis, G.. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal. 2002; 325 (7374): 1199-1201

    Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., Moffitt, T. E.. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal. 2002; 325 (7374): 1212-1213

    Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., Lewis, G.. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007; 370 (9584): 319-328

    Bersani, G., Orlandi, V., Gherardelli, S., Pancheri, P.. Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology. Psychopathology. 2002; 35 (5): 289-295

    Bersani, G., Orlandi, V., Kotzalidis, G. D., Pancheri, P.. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. European Archives of Psychiatry and Clinical Neuroscience. 2002; 252 (2): 86-92

    Compton, M. T., Furman, A. C., Kaslow, N. J.. Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample. Schizophrenia Research. 2004; 71 (1): 61-64

  • Metrics
    No metrics available
Share - Bookmark